These results may be explained by the fact that the ligand Cet had a strong bind force to the EGFR expressed in the surface of A549 and this characteristic of Cet could as the driving force for the delivery system to actively track tumor cells and decrease the side-effects to original cells. Here, EGFR is linked to neoplasm.